CosmosID Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 38

Employees

  • Latest Deal Type
  • 2ndary - Private

CosmosID General Information

Description

Developer of a microbial genomics platform designed to offer metagenomic microbial identification. The company's platform focuses on the rapid characterization of microorganisms, pathogens, and anti-microbial resistance for infectious disease identification, food safety inspections, pharmaceutical discovery, public health surveillance, and microbiome analysis, enabling physicians to have improved and effective treatment options.

Contact Information

Website
www.cosmosid.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 20030 Century Boulevard
  • Suite 300
  • Germantown, MD 20874
  • United States
+1 (703)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Cmbio
Vertical(s)
Big Data, Life Sciences
Corporate Office
  • 20030 Century Boulevard
  • Suite 300
  • Germantown, MD 20874
  • United States
+1 (703)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CosmosID Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Sep-2021 Completed Generating Revenue
4. Debt - PPP 10-Apr-2020 Completed Generating Revenue
3. Later Stage VC (Series B) 27-Jan-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Aug-2011 $3.54M $5.87M Completed Startup
1. Angel (individual) 30-Oct-2008 $2.33M $2.33M Completed Startup
To view CosmosID’s complete valuation and funding history, request access »

CosmosID Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series B-1
Series A 48,000,000 $0.001000 8% $0.15 $0.15 1x $0.15 22.13%
To view CosmosID’s complete cap table history, request access »

CosmosID Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a microbial genomics platform designed to offer metagenomic microbial identification. The company's platfor
Biotechnology
Germantown, MD
38 As of 2024

Rockville, MD
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CosmosID Competitors (19)

One of CosmosID’s 19 competitors is OpGen, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OpGen Formerly VC-backed Rockville, MD
Microbiotica Venture Capital-Backed Cambridge, United Kingdom
Vizgen Venture Capital-Backed Cambridge, MA
Avitide Formerly VC-backed Lebanon, NH
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom
You’re viewing 5 of 19 competitors. Get the full list »

CosmosID Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

CosmosID Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250182850-A1 Creation or use of anchor-based data structures for sample-derived characteristic determination Pending 06-Feb-2025
EP-2972309-A1 Characterization of biological material using unassembled sequence information, probabilistic methods and trait-specific database catalogs Inactive 15-Mar-2013
JP-2016518822-A Characterization of biological materials using unassembled sequence information, probabilistic methods, and trait-specific database catalogs Active 15-Mar-2013
JP-6644672-B2 Characterization of biological materials using unassembled sequence information, stochastic methods, and trait-specific database catalogs Active 15-Mar-2013
US-20140288844-A1 Characterization of biological material in a sample or isolate using unassembled sequence information, probabilistic methods and trait-specific database catalogs Inactive 15-Mar-2013 G16B40/00
To view CosmosID’s complete patent history, request access »

CosmosID Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CosmosID Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Applied Value Growth/Expansion Minority
Battelle Ventures Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Garden Growth Capital Growth/Expansion Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

CosmosID FAQs

  • When was CosmosID founded?

    CosmosID was founded in 2008.

  • Where is CosmosID headquartered?

    CosmosID is headquartered in Germantown, MD.

  • What is the size of CosmosID?

    CosmosID has 38 total employees.

  • What industry is CosmosID in?

    CosmosID’s primary industry is Biotechnology.

  • Is CosmosID a private or public company?

    CosmosID is a Private company.

  • What is CosmosID’s current revenue?

    The current revenue for CosmosID is .

  • How much funding has CosmosID raised over time?

    CosmosID has raised $11.9M.

  • Who are CosmosID’s investors?

    Applied Value, Battelle Ventures, , , and Garden Growth Capital are 5 of 9 investors who have invested in CosmosID.

  • Who are CosmosID’s competitors?

    OpGen, Microbiotica, Vizgen, Avitide, and QuantuMDx are some of the 19 competitors of CosmosID.

  • When was CosmosID acquired?

    CosmosID was acquired on 01-Sep-2021.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »